Evidence map›Paper›PMID 25864108›Full record

ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2015

A novel component from citrus, ginger, and mushroom family exhibits antitumor activity on human meningioma cells through suppressing the Wnt/β-catenin signaling pathway.

Arabinda Das, Rickey Miller, Philip Lee, Chrysanthe Alyssa Holden, Scott M Lindhorst, Jerry Jaboin, William A Vandergrift, Naren L Banik, Pierre Giglio, Abhay K Varma and 2 more

Open access · greenAbstract read
In one paragraph

Article in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. CanPharmaceuticals (Basel, Switzerland) · 2025
    Review
  5. Meningiomas in Rubinstein-Taybi syndrome: A case report and comprehensive review.Journal of neuropathology and experimental neurology · 2025
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Evaluating anti-tumor activity of palbociclib plus radiation in anaplastic and radiation-induced meningiomas: pre-clinical investigations.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2020
    Article
  14. Article
  15. Ganoderic acid A/DM-induced NDRG2 over-expression suppresses high-grade meningioma growth.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Arabinda DasDepartment of Neurosurgery, Medical University of South Carolina, Charleston, SC, 29425, USA. dasa@musc.edu.
Rickey MillerDepartment of Neurosurgery, Medical University of South Carolina, Charleston, SC, 29425, USA.
Philip LeeDepartment of Neurosurgery, Medical University of South Carolina, Charleston, SC, 29425, USA.
Chrysanthe Alyssa HoldenDepartment of Neurosurgery, Medical University of South Carolina, Charleston, SC, 29425, USA.
Scott M LindhorstDepartment of Neurosurgery, Medical University of South Carolina, Charleston, SC, 29425, USA.
Jerry JaboinDepartment of Radiation Oncology, School of Medicine, Washington University, St. Louis, MO, 63110, USA.
William A VandergriftDepartment of Neurosurgery, Medical University of South Carolina, Charleston, SC, 29425, USA.
Naren L BanikDepartment of Neurosurgery, Medical University of South Carolina, Charleston, SC, 29425, USA.
Pierre GiglioDepartment of Neurosurgery, Medical University of South Carolina, Charleston, SC, 29425, USA.
Abhay K VarmaDepartment of Neurosurgery, Medical University of South Carolina, Charleston, SC, 29425, USA.
Jeffery J RaizerDepartment of Neurology and Northwestern Brain Tumor Institute, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Sunil J PatelDepartment of Neurosurgery, Medical University of South Carolina, Charleston, SC, 29425, USA.
Medical University of South Carolina · USNorthwestern University · USRalph H. Johnson VA Medical Center · USWashington University in St. Louis · US

Funding

CALPAIN ACTIVATION OF T CELLS IN DEMYELINATING DISEASER01NS041088 · NINDS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BANIK, NAREN L · 2001 to 2009
$2.9M
CALPAIN IN THE PATHOPHYSIOLOGY OF DEMYELINATING DISEASER01NS038146 · NINDS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BANIK, NAREN L · 1999 to 2003
$918k
BLRD VA I01 BX001262NINDS NIH HHS NS-38146NINDS NIH HHS NS-41088NINDS NIH HHS R01 NS038146NINDS NIH HHS R01 NS041088
6 · The paper itself

Abstract

Recurrent meningiomas constitute an uncommon but significant problem after standard (surgery and radiation) therapy failure. Current chemotherapies (hydroxyurea, RU-486, and interferon-α) are only of marginal benefit. There is an urgent need for more effective treatments for meningioma patients who have failed surgery and radiation therapy. Limonin, Tangeritin, Zerumbone, 6-Gingerol, Ganoderic Acid A, and Ganoderic Acid DM are some of the plant derivatives that have anti-tumorgenic properties and cause cell death in meningioma cells in vitro. Due to its ease of administration, long-term tolerability, and low incidence of long-term side effects, we explored its potential as a therapeutic agent against meningiomas by examining their efficacy in vitro against meningioma cells. Treatment effects were assessed using MTT assay, Western blot analysis, caspases assay, and DNA fragmentation assay. Results indicated that treatments of IOMM-Lee and CH157MN meningioma cells with Limonin, Tangeritin, Zerumbone, 6-Gingerol, Ganoderic Acid A, and Ganoderic Acid DM induced apoptosis with enhanced phosphorylation of glycogen synthase kinase 3 β (GSK3β) via inhibition of the Wnt5/β-catenin pathway. These drugs did not induce apoptosis in normal human neurons. Other events in apoptosis included downregulation of tetraspanin protein (TSPAN12), survival proteins (Bcl-XL and Mcl-1), and overexpression apoptotic factors (Bax and caspase-3). These results provide preliminary strong evidence that medicinal plants containing Limonin, Tangeritin, 6-Gingerol, Zerumbone, Ganoderic Acid A, and Ganoderic Acid DM can be applied to high-grade meningiomas as a therapeutic agent, and suggests that further in vivo studies are necessary to explore its potential as a therapeutic agent against malignant meningiomas.

Indexed as

ApoptosisCatecholsCell Line, TumorDNA FragmentationFatty AlcoholsFlavonesGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaHeptanoic AcidsHumansLanosterolLimoninsMeningiomaSesquiterpenesTriterpenesWnt Signaling Pathway3,7-dioxolanosta-8,24-dien-26-oic acidCatecholsFatty AlcoholsFlavonesganoderic acid AgingerolGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaGSK3B protein, humanHeptanoic AcidsLanosterollimoninLimoninsSesquiterpenestangeretinTriterpeneszerumboneApoptosisCateninGingerLemonMeningiomaMushroomWnt

Identifiers

PMID25864108
PMCPMC9499733
OpenAlexW1999679403

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.